Trofinetide approved for children and adults with Rett syndrome (RTT): A therapeutics bulletin of the American College of Medical Genetics and Genomics (ACMG)

Pavalan Selvam, Carlos F. Mares Beltrán, Kuntal Sen, Andrés Morales Corado

Open source

DOI
10.1016/j.gimo.2024.101856
Published
2024
Container
Genetics in Medicine Open
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.gimo.2024.101856,
  title = {Trofinetide approved for children and adults with Rett syndrome (RTT): A therapeutics bulletin of the American College of Medical Genetics and Genomics (ACMG)},
  author = {Pavalan Selvam and Carlos F. Mares Beltrán and Kuntal Sen and Andrés Morales Corado},
  year = {2024},
  journal = {Genetics in Medicine Open},
  doi = {10.1016/j.gimo.2024.101856},
  url = {https://doi.org/10.1016/j.gimo.2024.101856}
}

RIS

TY  - JOUR
TI  - Trofinetide approved for children and adults with Rett syndrome (RTT): A therapeutics bulletin of the American College of Medical Genetics and Genomics (ACMG)
AU  - Pavalan Selvam
AU  - Carlos F. Mares Beltrán
AU  - Kuntal Sen
AU  - Andrés Morales Corado
PY  - 2024
JO  - Genetics in Medicine Open
DO  - 10.1016/j.gimo.2024.101856
UR  - https://doi.org/10.1016/j.gimo.2024.101856
ER  - 

APA

Selvam, P., Beltrán, C. F. M., Sen, K., & Corado, A. M. (2024). Trofinetide approved for children and adults with Rett syndrome (RTT): A therapeutics bulletin of the American College of Medical Genetics and Genomics (ACMG). Genetics in Medicine Open. https://doi.org/10.1016/j.gimo.2024.101856

Source records